Keyphrases
Varenicline
100%
Asthma Patients
100%
Smoking Cessation
100%
Asthmatic
37%
Placebo Groups
37%
Smokers
25%
Relapse Rate
25%
Asthma
25%
General Health
25%
Quit Smoking
25%
Health Quality
25%
Methacholine Challenge
12%
Randomized Placebo-controlled Trial
12%
Current Smokers
12%
Success Probability
12%
Tobacco Use
12%
Airway Hyperresponsiveness
12%
Treatment Resistance
12%
High Probability
12%
Symptom Score
12%
Cigarette
12%
Quit Rate
12%
Pack-years
12%
Lung Function
12%
Effective Compounds
12%
Placebo
12%
Asthma Symptom Score
12%
End of Treatment
12%
Parallel Design
12%
COPD Patients
12%
Asthma Control
12%
Smoking Status
12%
Young Smokers
12%
Treatment Duration
12%
Long-term Mortality
12%
Double-blind Trial
12%
Long-term Morbidity
12%
Medicine and Dentistry
Asthma
100%
Varenicline
100%
Nicotine Withdrawal
100%
Placebo
62%
Smoking
50%
Recurrence Risk
25%
Patient with Asthma
12%
Asthmatic State
12%
Lung
12%
Population
12%
Respiratory Tract Allergy
12%
Chronic Obstructive Pulmonary Disease
12%
Methacholine
12%
Tobacco Use
12%
Pharmacology, Toxicology and Pharmaceutical Science
Asthma
100%
Varenicline
100%
Placebo
62%
Recurrence Risk
25%
Methacholine
12%
Chronic Obstructive Lung Disease
12%
Respiratory Tract Allergy
12%
Immunology and Microbiology
Asthma
100%
Respiratory Tract Allergy
20%
Asthmatic State
20%
Population
20%